Background: Enterovirus (EV) can cause gastroenteritis and are known to replicate in Peyer's patches of terminal ileum. EV has been found in the intestinal specimens from immunocompromised patients with regional enteritis, and another study demonstrates the presence of enterovirus in the resected terminal ileum of immunocompetent pediatric patients with Crohn's disease (CD). Cluster outbreaks of CD have also been reported in the literature but the cause of the disease remains elusive. Materials and Methods: A small cluster of pathologically proven CD occurred in our geographic area in 2004-2005, concurrently with an epidemic of Echovirus 18 (E18) meningitis. Serum samples of these and other CD patients and control subjects were tested for neutralizing antibodies of 11 common typeable enteroviruses and Echovirus 18; and tissue samples of CD patients, and terminal ileum and colon biopsies of normal controls were tested for the presence of viral capsid protein 1 (VP1) by immunoperoxidase staining. Results: Immunoperoxidase staining demonstrated VP1 in a rare epithelial granuloma, in diseased muscle of terminal ileum and also in colon biopsies of CD patients. Significantly elevated E18 neutralizing antibody was found in patients with pathologically-proven Crohn's disease, as compared to control subjects. Conclusion: In this small observational study, EV VP1 is consistently demonstrated in tissue samples of CD patients as compared to control subjects; and neutralizing antibody for E18 was found in all of the patients with available serum samples. Larger cross-sectional studies will be needed to define the role of E18 in this chronic disease.
Introduction
Enteroviruses (EV) are common causes of gastrointestinal, respiratory and non-specific flu-like illnesses, followed by disseminated infections in some cases.
Many cases may be asymptomatic. Based on a 25-year surveillance study, published by the Centers for Diseases Control (CDC), it is estimated as many as 10 -15 million of the U.S. population would develop symptomatic infection annually [1] . However, most infectious diseases specialists and gastroenterologists are not familiar with these infections, and even modern stool PCR test does not routinely test for these viruses.
Enteroviruses are known to replicate in Peyer's patch of terminal ileum, a gut-associated lymphoid tissue. The importance of Peyer's patches in the development of Crohn's disease (CD) is well-accepted, and EV has been reported to cause regional enteritis in a few patients with agammaglobulinemia [2] [3] [4] [5] . Recently, Nyström et al. documented the presence of enterovirus in the resected terminal ileum of immunocompetent pediatric patients with Crohn's disease [6] . Coxsackieviruses and echoviruses were both implicated but no specific serotype was diagnosed in these cases.
Echovirus 18 (E18) has been reported to cause epidemics of meningitis and gastroenteritis in the last 25 years; the major outbreaks were between years 1986-1987 and 1995-2005 [1] . In our local area, E18 was found in many CSF samples of patients with viral meningitis between 2004 and 2005 by viral capsid protein 1 (VP1) gene sequencing, using a previously described method [7] ; at the same time we observed small cluster outbreaks of Crohn's disease in adults and pediatric patients (n = 4). We asked the question of whether E18 could be associated with Crohn's disease.
Materials and Methods
Patients with clinical and pathologic diagnosis of CD were evaluated by at least one of the physician authors: 4 patients during the outbreak, 2 other patients who had known Crohn's disease acquired 20 years earlier and 4 patients diagnosed in 2010-2012 were included in the study (Table 1) . Patients gave consent to obtain serum and archived tissue samples for viral antibody and immunochemical studies, respectively. Normal patients with prior screening colonoscopies and random biopsies of the colon/terminal ileum were enrolled as control subjects (n = 78). In addition, patients seen in clinic for the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome in the same periods were screened for the presence of E18 neutralizing antibody (n-85) as control subjects. The study was approved by the Institution Review Board of Providence Little Company of Mary Hospital, Torrance CA.
Immunoperoxidase staining. Immunoperoxidase staining of the paraffin-embedded intestinal tissues was performed with an enterovirus-specific murine monoclonal antibody (mAb) directed against a highly conserved viral capsid protein (VP1) sequence (5D8/1 at 1:2000 dilutions, Dako, Carpenteria, CA) Open Journal of Gastroenterology [14] .
All the staining runs were done manually since the use of semi-automated stainer resulted in unacceptable background staining even with more dilution of the primary antibody.
Cell lines and growth condition. Buffalo green monkey kidney cells-with human decay accelerating factor (BGMK-DAF cells) and CaCO 2 cells were purchased from Diagnostic Hybrid (Athens, Oh), and American Tissue Culture Company (ATCC, Manassas, VA), respectively. Cells were grown in advance minimal essential media (AMEM, life technology, Grand Island, NY) supplemented with 2% fetal calf serum at 37˚C with 5% CO 2 .
Neutralizing antibody assay. For 3 patients, antibody titers to Coxsackievirus B1, 2, 3, 4, 5, 6 and echovirus 6, 7, 9, 11, 30 by micro-neutralization assay were performed by ARUP laboratory, Salt lake city, Utah. Negative titer was <1:10 and a titer of ≥1:80 was considered as evidence of past or current infection.
In-house neutralization assay: For most of the serum samples, a modified in-house screening neutralization assay was used to determine titers of neutralizing antibody for the same 11 viruses. CVB1-6, echoviruses 6, 7, 9, 11, 30 were purchased from ATCC. Approximately 50 µL of 4 × quantity of viruses, consistently caused complete lysis of BGMK-DAF cells in 48 -72 hours, was mixed with 50 µL of 1:40 dilution of the serum samples for one hour at room tempera-Open Journal of Gastroenterology ture before adding to confluent monolayer of BGMK-DAF cells in 24-well plate in duplicates. In 48 -72 hours the cells were fixed with 4% formaldehyde, washed and stained with crystal violet. Neutralization is defined as complete protection of the monolayer, and the antibody titers was expressed as < or ≥ 1:80 for negative or positive neutralization, respectively. For viruses that did not lyse the monolayers during repeated assay, the results were reported as not done (ND). E18 neutralization assay. CSF isolates of E18 from patients with viral meningitis from the same periods as the Crohn's diseases outbreak were genotyped in 2012, using VP1 RT-PCR and sequencing as described by Oberste et al. [7] . Although high M.O.I. of E18 could lyse BGMK-DAF and CaCO 2 cells within one week of virus inoculation, much smaller inoculum did not result in lysis or plaque formation in either cell monolayer for over 10 -14 days; and growth was much slower in CaCO 2 cells. A modified protocol was used to quantitate enterovirus RNA within the infected cells in 48 hours after infection. Viruses equivalent to 5000 -7500 copies of EV RNA were pre-incubated with and without 1:40 dilution of serum samples for 1/2 hour before adding to the monolayer of CaCO 2 cells for 2 hours. The infected monolayers were washed with Hank balanced salt solution twice and refed with media. In 48 hours, the monolayers of duplicate wells were washed, lysed in RLT buffer, and the RNA of the pooled lysates extracted using the RNeasy mini kit (Qiagen, Valencia, Ca). Enterovirus RNA was quantitated using Pan-enterovirus Amplifluor primers kit with cDNA standard (Millipore, catalog # AMP3100), Qiagen one-step RT-PCR enzyme kit and
Step-one plus real-time PCR thermocycler (Applied Biosystem, Palo Alto, Ca). 2 Log 10 reduction of viral RNA in the wells treated with antibody comparing to wells with no added antibody was considered as evidence for neutralization at a titer of ≥1:80.
Enteroviral RNA testing of the tissue specimens: Four 10 µM paraffin sections of the intestine tissue specimens from CD patients and controls were processed with PureLink FFPE RNA isolation kit (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. Extracted RNA was amplified for enterovirus RNA as described above [8] .
Case Table 1 .
Result of Immunochemical Studies
For case 3, immunoperoxidase staining with 5 D8/1 demonstrated viral protein in a rarely found granuloma of TI biopsy (Figure 1(A) ) whereas staining with Figure 1 . Crohn's disease. Immunoperoxidase staining of TI, colon biopsies and resected small bowel segment with enterovirus-specific mAb 5 D8/1 for enteroviral capsid protein 1, with prior blocking with rabbit anti-CKb and anti-ATPase (see method section). (A) demonstrated viral protein in a rarely found granuloma of TI biopsy of case 3 (400x magnification), whereas (B) showed negative staining when performed with CMV mAb (400x). (C) showed positive staining in the sigmoid colon epithelium of patients 1 and 2 (400x), but not in biopsies of TI and other more inflamed areas of colon (400x, (D)). For patient 4, immunostaining demonstrated extensive enteroviral protein in the muscles of involved segment (IE 100x, (F) 400x). In an adjacent area, much less viral protein was seen in the muscles surrounding an intact myenteric plexus ((G), 400x), although viral protein was not demonstrated in the muscles of uninvolved margins of TI and cecum ((H), 400x). Open Journal of Gastroenterology CMV mAb showed negative result (Figure 1(B) ). EV staining of her colon biopsies showed negative results (photo not shown). For patients 1 and 2, staining for EV VP1 showed positive staining in the sigmoid colon samples (Figure 1(C) ), but not in biopsies of TI and other more inflamed areas of colon (Figure 1(D) ).
For patient 4, immunostaining demonstrated extensive enteroviral protein in themuscles of involved segment (Figure 1(E) , Figure 1(F) ). In an adjacent area, much less viral protein was seen in the muscles surrounding an intact myenteric plexus (Figure 1(G) ), although viral protein was not demonstrated in the muscles of uninvolved margins of TI and cecum (Figure 1(H) ). Similar findings were demonstrated in 3 other Crohn's disease patients who had resection of TI.
Staining of the same sections with CMV antibody showed negative results (data not shown).
Overall, 8/10 of the patients had positive EV staining of colon epithelium ( 
Discussion
The small epidemic of CD patients and concurrent isolation of E18 in CSF specimens from patients with viral meningitis during the same periods provided the clues for this investigation. The cluster outbreak in a pair of identical twin teenagers, living in an area highly endemic for enterovirus infection due to frequently contaminated drinking water [10] , was consistent with an environmen-Open Journal of Gastroenterology tal factor for this disease. The finding of neutralizing antibody to E18 in all eight cases of CD with available serum samples, as compared to 11/85 control subjects living the same geographic area in the same periods supports the importance of E18 in CD cases. All the cases have pathologic evidence of EV protein in the biopsy or resected intestinal samples.
The inability to detect EV RNA in the inflamed colon was not unexpected due to the severe inflammatory response in the intestinal tissue specimens. VP 1 protein was not detected in multiple biopsies of the severely inflamed colon, but was more obvious in less inflamed areas. It is possible that the host inflammatory response interfered with viral RNA replication and viral protein synthesis resulting in false-negative results.
It was interesting that E18 was neutralized by serum samples from CD patients before incubating with CaCO 2 cells, but not with BGMK-DAF cells. The mechanism for this discrepancy is unknown but E18 replicated at least 40 -100 times faster in BGMK-DAF cells than in CaCO 2 cells, and could have overcome partial neutralization. Ironically, slow growth of E18 in CaCO 2 cell, derived from colonic adenocarcinoma, may have more relevance to CD, as compared to genetically-modified monkey kidney cells.
E18 may not be the only enterovirus associated with CD, but the occurrence of small epidemics in 2004-2005, and finding positive E18 antibody in patients acquired disease 20 years earlier and in the recent past supported its importance.
There are currently more than 65+ serotypes and perhaps close to 140 genotypes, it is likely that other strains may play a role in this disease. However, in the studied patients with CD, there were no consistently elevated antibody titers for 11 of the most common enteroviruses isolated in the past 30 years. Although patient #5 has significantly elevated antibody titers to CVB1 and CVB4, none of the other patients have similar findings. Heterotypic response to other enteroviruses may occur with the immune response to E18, but antibody raised in horses against E18 did not have a significant heterotypic reaction to other echoviruses, CVA1-24 and CVB1-6 or vice versa [14] .
There were observed (1986-1987 and 1995-2005 Death was reported for 1.8% of E18 cases with known outcomes [1] . Open Journal of Gastroenterology
Besides infections of the stomach [8] , enteroviruses can cause acute and chronic small bowel and colon infections [9] . Cluster outbreaks of intussusceptions [10] and small bowel obstruction and colonic volvulus, appendicitis in immunocompetent patients provided additional clues to the possible viral etiology [15] , author's manuscript in preparation). Clustering outbreaks of Crohn's disease have been reported [16] [17] . Although the involvement of the myenteric plexus is common in Crohn's disease [5] , infection of intestinal smooth muscles with proliferation, myofibroblastic transformation, hyper contraction and necrosis likely led to the transmural inflammation-a sine qua non of Crohn's disease [18] . Enteroviruses commonly infect skeletal and cardiac muscles and it can persist in these muscles in human and animal models of enterovirus infections [6] [11] [12] .
A major issue with diagnosis of enterovirus infection in a patient with Crohn's disease is that terminal ileum mucosa rarely stained with 5D8/1 but deeper biopsies could not be safely obtained by colonoscopy. A full-thickness specimen, i.e. a resected small intestine, will be needed to find viral protein. The colon involvement tends to be patchy in nature, and could be missed without multiple biopsies of the inflamed areas and adjacent areas. Ironically, areas of more intense inflammation, showed minimal or no viral protein, but adjacent areas with less inflammation have more stainable viral protein (author's unpublished observation). The potential cross-reaction between enterovirus VP1 protein epitope and that of human mitochondrial proteins have been previously addressed by other studies [11] [12] , and also in our laboratory using stomach biopsy samples [13] . Serotype-specific monoclonal antibody may have better sensitivity and specificity but it is not currently available. Significantly elevated titer of neutralizing antibody to E18 may be a useful diagnostic tool in patients with CD.
One of the weaknesses of these observations is that no other reagents are available for the diagnosis of E18 infection other than 5D8/1 monoclonal antibody, which has been showed to cross-react with other mitochondrial protein epitopes [11] [12] . The staining was performed with very low dilutions of this monoclonal antibody, and blocked with antibodies specific for the cross-reactive epitopes, creatine phosphokinase b and Na + /K + ATPase with identical results. Perhaps, type-specific monoclonal antibody will offer better staining of the tissues. Additional work on finding conserved enterovirus RNA sequences from tissue samples may add even stronger evidence for the role of enterovirus in this disease. Furthermore, larger cross-sectional studies of patient cohorts from different geographic areas will be needed to confirm the prevalence and importance of E18 in CD.
The mainstay of therapy for Crohn's disease is suppression of genetically-predisposed inflammatory responses [5] . If importance of E18 and other enteroviruses are confirmed by larger studies, specific antiviral drugs for enteroviruses may be investigated as an adjunctive therapy for Crohn's disease; and furthermore, vaccination against specific enteroviruses may potentially prevent a chronic, debilitating disease.
